Share Price and Basic Stock Data
Last Updated: October 29, 2025, 9:54 pm
| PEG Ratio | 0.61 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Religare Enterprises Ltd, operating in the finance and investments sector, reported a market capitalization of ₹8,864 Cr and a share price of ₹268. The company has shown a significant increase in revenue, with sales rising from ₹3,227 Cr in FY 2022 to ₹4,679 Cr in FY 2023, and further projected to reach ₹6,266 Cr in FY 2024 and ₹7,385 Cr in FY 2025. The quarterly sales figures illustrate a robust trend, with sales for March 2025 recorded at ₹2,028.41 Cr, up from ₹1,396.07 Cr in March 2023. This growth trajectory indicates strong operational performance and market demand. The operating profit margin (OPM) stood at 0.82%, reflecting operational challenges but also opportunities for improvement. The company’s recent revenue growth can be attributed to strategic initiatives and a focus on enhancing service offerings in a competitive financial landscape.
Profitability and Efficiency Metrics
Religare’s profitability metrics depict a fluctuating performance. The net profit for FY 2023 was reported at ₹3,169 Cr, a significant turnaround from previous losses, while the net profit margin stood at 2.49% in FY 2025. The interest coverage ratio (ICR) was strong at 9.22x, indicating a solid ability to meet interest obligations. However, the return on equity (ROE) was relatively low at 5.15%, suggesting that while the company has managed to achieve profitability, shareholder returns remain modest. The cash conversion cycle (CCC) improved to 4 days, indicating efficient management of working capital. Despite these positive signs, the operating profit showed a decline in some quarters, notably a negative OPM of -3.94% in December 2024, which raises concerns about cost control and pricing strategies amidst rising expenses.
Balance Sheet Strength and Financial Ratios
The balance sheet of Religare Enterprises shows a total equity of ₹331 Cr and reserves of ₹2,185 Cr, demonstrating a relatively healthy financial position. The company’s total borrowings have declined significantly to ₹233 Cr from ₹841 Cr in FY 2023, reflecting a focused effort on debt reduction. The long-term debt to equity ratio stood at 0.05, indicating a low reliance on debt financing, which is favorable for financial stability. However, the price-to-book value (P/BV) ratio of 3.09x suggests that the stock may be overvalued compared to its book value. The current ratio at 3.68 reflects strong liquidity, providing assurance to creditors and investors alike. However, the company’s return on capital employed (ROCE) at 8.39% indicates that capital efficiency remains an area needing improvement to enhance profitability.
Shareholding Pattern and Investor Confidence
Religare’s shareholding structure reflects a diverse investor base, with promoters holding 25.83% of the shares, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) accounted for 8.10% and 11.62%, respectively. The public holds a substantial 54.45% of the company. The significant increase in promoter holdings from 0% in previous quarters to 25.67% in March 2025 indicates renewed confidence from management in the company’s future. This shift may enhance investor sentiment and stabilize share prices. The number of shareholders stood at 74,058, indicating a broad base of retail participation. However, the decline in FII ownership from 19.60% in September 2022 to 8.10% in March 2025 may signal concerns regarding the company’s performance or market conditions, potentially impacting future stock liquidity and volatility.
Outlook, Risks, and Final Insight
Looking ahead, Religare Enterprises faces both opportunities and challenges. The strong revenue growth trend suggests potential for sustainable profitability, particularly if operational efficiencies are improved. However, the low ROE and fluctuating profit margins highlight risks associated with cost management and competitive pressures. The ongoing focus on reducing debt and enhancing shareholder value is commendable, but the company must also navigate market volatility and regulatory changes in the financial sector. Investor confidence appears to be stabilizing with increased promoter holdings, yet the decline in foreign institutional interest raises questions about long-term market perceptions. In a scenario where operational efficiencies are enhanced and market conditions remain favorable, the company could see improved profitability, while failure to address its cost structure may hinder growth prospects.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Religare Enterprises Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.7 Cr. | 40.0 | 67.7/36.4 | 41.9 | 43.5 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,448 Cr. | 309 | 495/280 | 15.8 | 102 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 38.7 Cr. | 0.55 | 2.42/0.46 | 3.76 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.19 Cr. | 8.47 | 12.7/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 28.8 Cr. | 56.2 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,822.91 Cr | 1,424.34 | 135.36 | 3,769.50 | 0.31% | 21.70% | 14.20% | 7.28 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 950.51 | 1,164.47 | 1,165.43 | 1,396.07 | 1,284.62 | 1,584.39 | 1,510.57 | 1,855.69 | 1,709.54 | 1,951.86 | 1,664.43 | 2,028.41 | 1,861.38 |
| Expenses | 922.76 | 1,117.22 | 1,020.44 | 1,149.40 | 1,146.62 | 1,483.01 | 1,454.77 | 1,832.77 | 1,652.55 | 1,875.95 | 1,729.95 | 1,795.99 | 1,846.08 |
| Operating Profit | 27.75 | 47.25 | 144.99 | 246.67 | 138.00 | 101.38 | 55.80 | 22.92 | 56.99 | 75.91 | -65.52 | 232.42 | 15.30 |
| OPM % | 2.92% | 4.06% | 12.44% | 17.67% | 10.74% | 6.40% | 3.69% | 1.24% | 3.33% | 3.89% | -3.94% | 11.46% | 0.82% |
| Other Income | 100.57 | 18.87 | 3.18 | 3,353.57 | 17.84 | 1.19 | 26.66 | 249.13 | 4.88 | 19.12 | 5.81 | 12.83 | 10.31 |
| Interest | 189.37 | 197.16 | 212.65 | 28.89 | 25.58 | 25.30 | 24.23 | 18.42 | 13.32 | 12.91 | 5.12 | 5.79 | 7.33 |
| Depreciation | 14.33 | 13.35 | 14.13 | 14.33 | 18.68 | 18.30 | 17.50 | 17.23 | 15.89 | 14.69 | 14.08 | 17.35 | 12.55 |
| Profit before tax | -75.38 | -144.39 | -78.61 | 3,557.02 | 111.58 | 58.97 | 40.73 | 236.40 | 32.66 | 67.43 | -78.91 | 222.11 | 5.73 |
| Tax % | 1.09% | 22.39% | 21.55% | 1.12% | 17.08% | 31.58% | 17.55% | 23.46% | 17.88% | -1.57% | -19.79% | 31.89% | -42.58% |
| Net Profit | -76.20 | -176.72 | -95.55 | 3,517.09 | 92.53 | 40.36 | 33.58 | 180.96 | 26.81 | 68.49 | -63.28 | 151.30 | 8.17 |
| EPS in Rs | -2.38 | -6.49 | -3.62 | 107.61 | 1.94 | 0.78 | 0.59 | 3.80 | 0.55 | 1.55 | -1.30 | 3.00 | 0.31 |
Last Updated: August 20, 2025, 4:30 am
Below is a detailed analysis of the quarterly data for Religare Enterprises Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,861.38 Cr.. The value appears to be declining and may need further review. It has decreased from 2,028.41 Cr. (Mar 2025) to 1,861.38 Cr., marking a decrease of 167.03 Cr..
- For Expenses, as of Jun 2025, the value is 1,846.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,795.99 Cr. (Mar 2025) to 1,846.08 Cr., marking an increase of 50.09 Cr..
- For Operating Profit, as of Jun 2025, the value is 15.30 Cr.. The value appears to be declining and may need further review. It has decreased from 232.42 Cr. (Mar 2025) to 15.30 Cr., marking a decrease of 217.12 Cr..
- For OPM %, as of Jun 2025, the value is 0.82%. The value appears to be declining and may need further review. It has decreased from 11.46% (Mar 2025) to 0.82%, marking a decrease of 10.64%.
- For Other Income, as of Jun 2025, the value is 10.31 Cr.. The value appears to be declining and may need further review. It has decreased from 12.83 Cr. (Mar 2025) to 10.31 Cr., marking a decrease of 2.52 Cr..
- For Interest, as of Jun 2025, the value is 7.33 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.79 Cr. (Mar 2025) to 7.33 Cr., marking an increase of 1.54 Cr..
- For Depreciation, as of Jun 2025, the value is 12.55 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 17.35 Cr. (Mar 2025) to 12.55 Cr., marking a decrease of 4.80 Cr..
- For Profit before tax, as of Jun 2025, the value is 5.73 Cr.. The value appears to be declining and may need further review. It has decreased from 222.11 Cr. (Mar 2025) to 5.73 Cr., marking a decrease of 216.38 Cr..
- For Tax %, as of Jun 2025, the value is -42.58%. The value appears to be improving (decreasing) as expected. It has decreased from 31.89% (Mar 2025) to -42.58%, marking a decrease of 74.47%.
- For Net Profit, as of Jun 2025, the value is 8.17 Cr.. The value appears to be declining and may need further review. It has decreased from 151.30 Cr. (Mar 2025) to 8.17 Cr., marking a decrease of 143.13 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.31. The value appears to be declining and may need further review. It has decreased from 3.00 (Mar 2025) to 0.31, marking a decrease of 2.69.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,361 | 4,128 | 4,895 | 3,709 | 2,675 | 2,371 | 2,384 | 2,513 | 3,227 | 4,679 | 6,266 | 7,385 | 7,506 |
| Expenses | 1,585 | 2,006 | 3,710 | 1,659 | 2,841 | 3,005 | 2,341 | 2,235 | 3,592 | 4,196 | 5,898 | 7,029 | 7,248 |
| Operating Profit | 1,775 | 2,122 | 1,184 | 2,050 | -167 | -634 | 43 | 278 | -364 | 483 | 368 | 356 | 258 |
| OPM % | 53% | 51% | 24% | 55% | -6% | -27% | 2% | 11% | -11% | 10% | 6% | 5% | 3% |
| Other Income | 25 | 58 | 1,012 | -316 | 60 | 10 | -157 | 17 | 137 | 3,473 | 263 | 12 | 48 |
| Interest | 1,584 | 1,658 | 1,879 | 1,840 | 1,271 | 854 | 855 | 733 | 750 | 641 | 112 | 63 | 31 |
| Depreciation | 34 | 37 | 36 | 31 | 30 | 26 | 61 | 59 | 53 | 56 | 72 | 62 | 59 |
| Profit before tax | 182 | 485 | 282 | -136 | -1,407 | -1,504 | -1,030 | -497 | -1,031 | 3,259 | 448 | 243 | 216 |
| Tax % | 85% | 34% | 79% | -10% | -16% | -0% | 1% | -4% | 49% | 3% | 22% | 25% | |
| Net Profit | 27 | 321 | 61 | -124 | -1,181 | -1,501 | -1,038 | -478 | -1,539 | 3,169 | 347 | 183 | 165 |
| EPS in Rs | -4.63 | 8.62 | -2.67 | -9.77 | -58.56 | -59.33 | -36.12 | -19.60 | -48.43 | 95.24 | 7.06 | 3.79 | 3.56 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1088.89% | -81.00% | -303.28% | -852.42% | -27.10% | 30.85% | 53.95% | -221.97% | 305.91% | -89.05% | -47.26% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1169.89% | -222.28% | -549.14% | 825.32% | 57.94% | 23.10% | -275.92% | 527.88% | -394.96% | 41.79% |
Religare Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 25% |
| 3 Years: | 32% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 17% |
| 3 Years: | 28% |
| TTM: | 78% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 46% |
| 3 Years: | 21% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 1:05 pm
Balance Sheet
Last Updated: October 10, 2025, 2:51 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 150 | 178 | 178 | 178 | 178 | 217 | 258 | 259 | 319 | 324 | 330 | 331 |
| Reserves | 2,982 | 3,705 | 3,660 | 2,549 | 1,658 | 616 | -157 | -306 | -1,301 | 1,734 | 2,013 | 2,185 |
| Borrowings | 14,073 | 16,491 | 20,247 | 14,956 | 9,945 | 6,717 | 5,356 | 4,940 | 4,878 | 841 | 443 | 233 |
| Other Liabilities | 3,920 | 5,064 | 3,344 | 3,355 | 2,081 | 2,023 | 2,673 | 3,832 | 5,467 | 5,193 | 6,686 | 8,480 |
| Total Liabilities | 21,125 | 25,439 | 27,429 | 21,038 | 13,862 | 9,573 | 8,130 | 8,725 | 9,362 | 8,092 | 9,472 | 11,229 |
| Fixed Assets | 1,981 | 2,128 | 1,785 | 103 | 80 | 83 | 175 | 117 | 127 | 196 | 161 | 145 |
| CWIP | 12 | 4 | 4 | 12 | 11 | 14 | 13 | 12 | 2 | 5 | 6 | 8 |
| Investments | 3,344 | 4,363 | 2,700 | 1,983 | 1,197 | 1,438 | 2,023 | 3,190 | 3,836 | 5,094 | 6,718 | 8,700 |
| Other Assets | 15,788 | 18,944 | 22,941 | 18,940 | 12,574 | 8,038 | 5,919 | 5,406 | 5,397 | 2,797 | 2,587 | 2,376 |
| Total Assets | 21,125 | 25,439 | 27,429 | 21,038 | 13,862 | 9,573 | 8,130 | 8,725 | 9,362 | 8,092 | 9,472 | 11,229 |
Below is a detailed analysis of the balance sheet data for Religare Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 331.00 Cr.. The value appears strong and on an upward trend. It has increased from 330.00 Cr. (Mar 2024) to 331.00 Cr., marking an increase of 1.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,185.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,013.00 Cr. (Mar 2024) to 2,185.00 Cr., marking an increase of 172.00 Cr..
- For Borrowings, as of Mar 2025, the value is 233.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 443.00 Cr. (Mar 2024) to 233.00 Cr., marking a decrease of 210.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 8,480.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,686.00 Cr. (Mar 2024) to 8,480.00 Cr., marking an increase of 1,794.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 11,229.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,472.00 Cr. (Mar 2024) to 11,229.00 Cr., marking an increase of 1,757.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2024) to 145.00 Cr., marking a decrease of 16.00 Cr..
- For CWIP, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Mar 2025, the value is 8,700.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,718.00 Cr. (Mar 2024) to 8,700.00 Cr., marking an increase of 1,982.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,376.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,587.00 Cr. (Mar 2024) to 2,376.00 Cr., marking a decrease of 211.00 Cr..
- For Total Assets, as of Mar 2025, the value is 11,229.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,472.00 Cr. (Mar 2024) to 11,229.00 Cr., marking an increase of 1,757.00 Cr..
Notably, the Reserves (2,185.00 Cr.) exceed the Borrowings (233.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -13.00 | -14.00 | -19.00 | -12.00 | -176.00 | -640.00 | 38.00 | 274.00 | -368.00 | -358.00 | -75.00 | 123.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 52 | 35 | 60 | 42 | 53 | 14 | 28 | 21 | 14 | 8 | 4 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 52 | 52 | 35 | 60 | 42 | 53 | 14 | 28 | 21 | 14 | 8 | 4 |
| Working Capital Days | -303 | -326 | -257 | -187 | -250 | -224 | -352 | -264 | -387 | -275 | -291 | -334 |
| ROCE % | 11% | 11% | 9% | 10% | -1% | -7% | -0% | 4% | -6% | 16% | 9% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Large and Midcap Fund | 3,000,000 | 2.48 | 67.58 | 3,000,000 | 2025-04-22 15:56:54 | 0% |
| Motilal Oswal ELSS Tax Saver Fund | 2,900,000 | 2.37 | 65.32 | 2,900,000 | 2025-04-22 15:56:54 | 0% |
| Motilal Oswal Balance Advantage Fund | 2,740,728 | 7.4 | 61.73 | 2,740,728 | 2025-04-22 15:56:54 | 0% |
| Motilal Oswal Focused Fund | 2,022,299 | 2.56 | 45.55 | 2,022,299 | 2025-04-22 17:25:21 | 0% |
| Motilal Oswal Equity Hybrid Fund | 894,303 | 4.7 | 20.14 | 894,303 | 2025-04-22 15:56:54 | 0% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 340,598 | 1.34 | 7.67 | 340,598 | 2025-04-22 15:56:54 | 0% |
| Motilal Oswal Multi Asset Fund | 250,000 | 5.12 | 5.63 | 250,000 | 2025-04-22 17:25:21 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.79 | 7.13 | 96.06 | -51.33 | -19.65 |
| Diluted EPS (Rs.) | 3.78 | 7.07 | 94.67 | -51.33 | -19.65 |
| Cash EPS (Rs.) | 7.42 | 12.71 | 99.67 | -46.58 | -16.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 76.09 | 70.96 | 63.59 | -16.69 | 11.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 76.09 | 70.96 | 63.59 | -16.69 | 11.48 |
| Revenue From Operations / Share (Rs.) | 222.41 | 189.09 | 144.53 | 101.11 | 95.86 |
| PBDIT / Share (Rs.) | 10.36 | 11.60 | 20.20 | -7.46 | 11.04 |
| PBIT / Share (Rs.) | 8.48 | 9.43 | 18.46 | -9.14 | 8.77 |
| PBT / Share (Rs.) | 7.36 | 13.58 | 100.71 | -32.34 | -19.17 |
| Net Profit / Share (Rs.) | 5.54 | 10.54 | 97.93 | -48.26 | -18.41 |
| NP After MI And SOA / Share (Rs.) | 2.04 | 7.06 | 95.24 | -48.43 | -19.60 |
| PBDIT Margin (%) | 4.65 | 6.13 | 13.97 | -7.38 | 11.51 |
| PBIT Margin (%) | 3.81 | 4.98 | 12.77 | -9.03 | 9.15 |
| PBT Margin (%) | 3.30 | 7.18 | 69.68 | -31.98 | -20.00 |
| Net Profit Margin (%) | 2.49 | 5.57 | 67.75 | -47.72 | -19.21 |
| NP After MI And SOA Margin (%) | 0.91 | 3.73 | 65.89 | -47.89 | -20.44 |
| Return on Networth / Equity (%) | 2.67 | 9.95 | 149.76 | 0.00 | 0.00 |
| Return on Capital Employeed (%) | 3.36 | 4.56 | 10.92 | -19.54 | 10.06 |
| Return On Assets (%) | 0.59 | 2.43 | 38.07 | -16.50 | -5.82 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | -11.92 |
| Total Debt / Equity (X) | 0.05 | 0.18 | 0.35 | -4.92 | -103.85 |
| Asset Turnover Ratio (%) | 0.70 | 0.70 | 0.53 | 0.00 | 0.00 |
| Current Ratio (X) | 3.68 | 3.25 | 2.81 | 1.11 | 1.16 |
| Quick Ratio (X) | 3.68 | 3.25 | 2.81 | 1.11 | 1.16 |
| Interest Coverage Ratio (X) | 9.22 | 4.09 | 1.04 | -0.32 | 0.39 |
| Interest Coverage Ratio (Post Tax) (X) | 5.94 | 2.25 | 0.80 | -1.08 | 0.34 |
| Enterprise Value (Cr.) | 7739.48 | 7089.94 | 5230.88 | 7032.76 | 5988.22 |
| EV / Net Operating Revenue (X) | 1.05 | 1.14 | 1.12 | 2.18 | 2.41 |
| EV / EBITDA (X) | 22.60 | 18.53 | 8.01 | -29.55 | 20.91 |
| MarketCap / Net Operating Revenue (X) | 1.06 | 1.11 | 1.00 | 1.29 | 0.91 |
| Price / BV (X) | 3.09 | 2.95 | 2.28 | -4.22 | -48.26 |
| Price / Net Operating Revenue (X) | 1.06 | 1.11 | 1.00 | 1.29 | 0.91 |
| EarningsYield | 0.01 | 0.03 | 0.65 | -0.37 | -0.22 |
After reviewing the key financial ratios for Religare Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.79. This value is below the healthy minimum of 5. It has decreased from 7.13 (Mar 24) to 3.79, marking a decrease of 3.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.78. This value is below the healthy minimum of 5. It has decreased from 7.07 (Mar 24) to 3.78, marking a decrease of 3.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 7.42. This value is within the healthy range. It has decreased from 12.71 (Mar 24) to 7.42, marking a decrease of 5.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 76.09. It has increased from 70.96 (Mar 24) to 76.09, marking an increase of 5.13.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 76.09. It has increased from 70.96 (Mar 24) to 76.09, marking an increase of 5.13.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 222.41. It has increased from 189.09 (Mar 24) to 222.41, marking an increase of 33.32.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 10.36. This value is within the healthy range. It has decreased from 11.60 (Mar 24) to 10.36, marking a decrease of 1.24.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.48. This value is within the healthy range. It has decreased from 9.43 (Mar 24) to 8.48, marking a decrease of 0.95.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.36. This value is within the healthy range. It has decreased from 13.58 (Mar 24) to 7.36, marking a decrease of 6.22.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 10.54 (Mar 24) to 5.54, marking a decrease of 5.00.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.04. This value is within the healthy range. It has decreased from 7.06 (Mar 24) to 2.04, marking a decrease of 5.02.
- For PBDIT Margin (%), as of Mar 25, the value is 4.65. This value is below the healthy minimum of 10. It has decreased from 6.13 (Mar 24) to 4.65, marking a decrease of 1.48.
- For PBIT Margin (%), as of Mar 25, the value is 3.81. This value is below the healthy minimum of 10. It has decreased from 4.98 (Mar 24) to 3.81, marking a decrease of 1.17.
- For PBT Margin (%), as of Mar 25, the value is 3.30. This value is below the healthy minimum of 10. It has decreased from 7.18 (Mar 24) to 3.30, marking a decrease of 3.88.
- For Net Profit Margin (%), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 5. It has decreased from 5.57 (Mar 24) to 2.49, marking a decrease of 3.08.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 8. It has decreased from 3.73 (Mar 24) to 0.91, marking a decrease of 2.82.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.67. This value is below the healthy minimum of 15. It has decreased from 9.95 (Mar 24) to 2.67, marking a decrease of 7.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 10. It has decreased from 4.56 (Mar 24) to 3.36, marking a decrease of 1.20.
- For Return On Assets (%), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 5. It has decreased from 2.43 (Mar 24) to 0.59, marking a decrease of 1.84.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.18 (Mar 24) to 0.05, marking a decrease of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.70. There is no change compared to the previous period (Mar 24) which recorded 0.70.
- For Current Ratio (X), as of Mar 25, the value is 3.68. This value exceeds the healthy maximum of 3. It has increased from 3.25 (Mar 24) to 3.68, marking an increase of 0.43.
- For Quick Ratio (X), as of Mar 25, the value is 3.68. This value exceeds the healthy maximum of 2. It has increased from 3.25 (Mar 24) to 3.68, marking an increase of 0.43.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.22. This value is within the healthy range. It has increased from 4.09 (Mar 24) to 9.22, marking an increase of 5.13.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.94. This value is within the healthy range. It has increased from 2.25 (Mar 24) to 5.94, marking an increase of 3.69.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,739.48. It has increased from 7,089.94 (Mar 24) to 7,739.48, marking an increase of 649.54.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.05. This value is within the healthy range. It has decreased from 1.14 (Mar 24) to 1.05, marking a decrease of 0.09.
- For EV / EBITDA (X), as of Mar 25, the value is 22.60. This value exceeds the healthy maximum of 15. It has increased from 18.53 (Mar 24) to 22.60, marking an increase of 4.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.06, marking a decrease of 0.05.
- For Price / BV (X), as of Mar 25, the value is 3.09. This value exceeds the healthy maximum of 3. It has increased from 2.95 (Mar 24) to 3.09, marking an increase of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.06, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Religare Enterprises Ltd:
- Net Profit Margin: 2.49%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.36% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.67% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.94
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.68
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 74.4 (Industry average Stock P/E: 135.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.49%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 1407, 14th Floor, Chiranjiv Tower, New Delhi Delhi 110019 | investorservices@religare.com http://www.religare.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Rashmi Saluja | Executive Chairperson |
| Mr. Hamid Ahmed | Independent Director |
| Mr. Praveen Kumar Tripathi | Independent Director |
| Mr. Malay Kumar Sinha | Independent Director |
| Mr. Ranjan Dwivedi | Independent Director |
| Mrs. Preeti Madan | Independent Director |
FAQ
What is the intrinsic value of Religare Enterprises Ltd?
Religare Enterprises Ltd's intrinsic value (as of 29 October 2025) is 237.93 which is 9.87% lower the current market price of 264.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 8,735 Cr. market cap, FY2025-2026 high/low of 320/202, reserves of ₹2,185 Cr, and liabilities of 11,229 Cr.
What is the Market Cap of Religare Enterprises Ltd?
The Market Cap of Religare Enterprises Ltd is 8,735 Cr..
What is the current Stock Price of Religare Enterprises Ltd as on 29 October 2025?
The current stock price of Religare Enterprises Ltd as on 29 October 2025 is 264.
What is the High / Low of Religare Enterprises Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Religare Enterprises Ltd stocks is 320/202.
What is the Stock P/E of Religare Enterprises Ltd?
The Stock P/E of Religare Enterprises Ltd is 74.4.
What is the Book Value of Religare Enterprises Ltd?
The Book Value of Religare Enterprises Ltd is 76.1.
What is the Dividend Yield of Religare Enterprises Ltd?
The Dividend Yield of Religare Enterprises Ltd is 0.00 %.
What is the ROCE of Religare Enterprises Ltd?
The ROCE of Religare Enterprises Ltd is 8.39 %.
What is the ROE of Religare Enterprises Ltd?
The ROE of Religare Enterprises Ltd is 5.15 %.
What is the Face Value of Religare Enterprises Ltd?
The Face Value of Religare Enterprises Ltd is 10.0.